Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Micro Exam 1 > Pogue: Pharmacokinetics > Flashcards

Pogue: Pharmacokinetics Flashcards

1
Q

Pharmacokinetics

Pharmacodynamics

A

Pharmacokinetics:
“What the body does to the drug”

Absorption
Distribution
Metabolism
Excretion

Pharmacodynamics
“What the drug does to the body”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Bioavailability

A

If give an antibiotic by any route other than
intravenous the fraction of the drug available for
use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Drugs with complete or near complete bioavailability (7):

A 
Fluoroquinolones
TMP-SMX
clindamycin
linezolid
tetracyclines
metronidazole
fluconazole
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Volume of Distribution
Definition:

Aminoglycosides vs Tigecycline

A

Measure of a drugs lipophilicity or hydrophilicity
• Can impact what antibiotics are ideal for
different sources of infection

– Aminoglycosides: Low Vd; hydrophilic
– Tigecycline: High Vd; lipophilic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clearance:

What happens with renal insufficiency?

A

Clearance is a measure of the removal of drug
from the body

– Key concept: many antimicrobials are renally cleared therefore dose adjustments needed in renal insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Half-life:

A

Amount of time it takes remove 50% of the drug from
the body
– Helps determine the dosing interval for a drug
– Important determinant of total drug removal and
“steady state”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How many half-lifes does it take to reach steady state?

A

4-5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When is loading dose given?

A

When drugs have long half-lives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When should bactericidal drugs be used?

A

With immunosuppressed or patients with serious infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Antimicrobial susceptibility

Susceptible

A

Susceptible

– PK/PD targets are achievable and you would expect common doses of the antimicrobial to lead to clinical success

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antimicrobial susceptibility

Intermediate

A

Intermediate
– MICs are elevated for the organism toward the
antimicrobial in question
– One MIGHT see clinical success with dose-optimization
strategies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Antimicrobial susceptibility

Resistant

A

Resistant
– PK/PD targets not obtainable- would not expect clinical
success with the agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

PK/PD targets associated with efficacy

T>MIC

A

T>MIC
– B-­‐lactams
– Macrolides
– Oxazolidinones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

PK/PD targets associated with efficacy

AUC/MIC

A 
AUC/MIC
– Vancomycin
– Fluoroquinolones
– Tetracyclines
– Polymyxins
– Daptomycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PK/PD targets associated with efficacy

Cmax/MIC

A

Cmax (peak)/MIC

– Aminoglycosides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Time dependent antibiotics:

Concentration independent or dependent?

What is the PK/PD parameter associated with efficacy?

What is the representative class?

A

Concentration independent: at a fixed value above the MIC (usually regarded as 4-5x MIC) there will be no added effect

T>MIC is the PK/PD parameter associated with efficacy
- Optimize the amount of time the conc. of the agent is above the MIC

B-lactams are the representative class
-penicillins, ephalosporins, carbapenems, aztreonam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Time dependent antibiotics:

How do targets differ for different agents?

  • Cephalosporins
  • PCN
  • Carbapenems
A

Target can differ for different agents

  • Cephalosporins 60%
  • PCN 50%
  • Carbapenems 35-40%
18
Q

What parameters will help determine serum concentrations?

A

Vd

Half life

19
Q

Time dependent antibiotics

Preferential dosing regimens

A

Smaller, more frequent dosing

20
Q

Peak concentration =

For aminoglycosides
For vancomycin:

A

Peak concentration – timing of blood draw is immediately after completion of the distribution phase

30 minutes post end of infusion for aminoglycosides
60 minutes post end of infusion for vancomycin
21
Q

Trough concentration:

Random concentration:

Extrapolated Cmax:

A

Trough concentration – drawn within 0-30 minutes before the next dose is given

Random concentration – drawn at any time between the peak and trough times

Extrapolated Cmax – mathematically calculated maximum drug concentration

22
Q

MIC:

MBC:

A

Traditional tests evaluating antibiotic activity against bacteria

MIC (minimum inhibitory concentration) lowest drug concentration that inhibits bacterial growth

MBC (minimum bactericidal concentration) lowest drug concentration that kills bacteria

MBCs are not routinely tested in the clinical setting

23
Q

Why is there no loading dose with B-lactam?

A

Small half life

24
Q

What are Monte Carlo simulations used for?

A

To extrapolate PK parameters/levels seen in small number of patients to large numbers

25
Q

What is PTA?

What is considered “good coverage?”

A

Probability of target attainment

PTA> 90%

26
Q

What are the simulations drivers of?

A

More recent breakpoint changes for cephalosporins, carbapenems in G- bacilli

27
Q

Concentration-dependent antibiotics

What 2 different PD parameters are associated with kill?

What are higher doses associated with?

A

Cmax/MIC

AUC/MIC

Bacterial killing

28
Q

Aminoglycosides

Target Cmax/MIC ratio is?

A

8-12:1

29
Q

Aminoglycosides

Why aren’t higher peaks associated with increased toxicity?

A

Higher peaks are not associated with increased toxicity as long as you can target low troughs for an “aminoglycoside free interval”

– Nephrotoxicity, ototoxicityAminoglycosides

30
Q

What is the post-antibiotic effect?

What is it for aminoglycosides?

A

Post antibiotic effect

– Describes a persistent suppression of microbial growth after a prior antimicrobial exposure

– Continued suppression of growth for a certain period of time despite drug concentrations that fall below the MIC

– With the aminoglycosides it is 4-6 hours

31
Q

Application of Cmax/MIC
Aminoglycoside Dosing

Traditional dosing vs. extended interval dosing

A

Traditional dosing
– 1-2 mg/kg q8h
– Targeting peaks of ~8-10; troughs of <1

Extended interval dosing
– 5-7 mg/kg q24h
– Allows us to shoot for higher troughs (~14-22) and thus target higher MIC organisms (i.e. P.aeruginosa)
- Also get lower troughs
– Take advantage of post-antibiotic effect
– Undetectable trough reduces or delays nephrotoxicity

32
Q

Application of AUC/MIC: Vancomycin

What is Vanco primarily used for?

What is the PK/PD goal AUC/MIC ratio?

What is used for a “surrogate” for reaching AUC/MIC targets?

Historically, what were target troughs?

A

Application of AUC/MIC: Vancomycin

Vancomycin primarily used for MRSA coverage

– PK/PD goal is an AUC/MIC ratio of ≥ 400 for invasive MRSA infections
– AUC’s not obtained in patients

33
Q

Application of AUC/MIC: Vancomycin

What is used for a “surrogate” for reaching AUC/MIC targets?

Historically, what were target troughs?

A

– A trough of 15-20 mcg/mL is used for a “surrogate” for reaching AUC/MIC targets

• Historically target troughs were 5-20 mcg/mL – Will hit AUC/MIC targets if the vancomycin MIC ≤ 1 mcg/mL
- The reason we switch to alternative agents for invasive MRSA infections when the MIC >1

34
Q

AUC/MIC Applications: FQs

What is AUC/MIC?

G+ vs G-

A

AUC/MIC is PK/PD parameter of interest

Different between G+ and G-

Levels not routinely obtained

35
Q

AUC/MIC Applications: FQs

Two main applications of FQs

A

S.pneumoniae target is AUC/MIC >30 (Free drug only)

G-, including P. aeruginosa
- AUC/MIC >125 (free drug 60-90)

36
Q

PK/PD application: CAP

What don’t respiratory FQs include?

Levofloxacin and CAP:

Moxifloxacin:
excellent agent for?

A

Respiratory FQ do not include ciprofloxacin
-Even at lower MIC (1.0) - unlikely to obtain goal AUC/MIC targets (even with high-dose cipro)

Levofloxacin and CAP
- High dose (750 mg daily) likely necessary to ensure adequate coverage

Moxifloxacin
- Due to low MICs, excellent agent for CAP

37
Q

FQ and Pseudomonas

Do FQs have good activity?
What is MIC90?
Moxifloxacin?
Cipro?
Levofloxacin vs Cipro:
A

No

MIC90 is 32 mcg/mL for all agents

For all intents and purposes moxifloxacin lacks anti-pseudomonal activity

Ciprofloxacin tends to be one dilution more potent

Levofloxacin (high dose) can get about twice as high of an AUC as ciprofloxacin (high dose)
- Making cipro and levofloxacin roughly equivalent anti-pseudomonal agents

38
Q

What is essential for optimizing AUC/MIC for pseudomonas?

A

High dose

Cipro 750 mg PO BID or 400 mg IV q8h
Levofloxacin 750 mg daily

39
Q

Synergistic Combinations:

Against Gram (-) bacilli:

Against Eneterococci:

A

Against Gram (-) bacilli: AMG + beta-lactam

Against Eneterococci: gentamicin/streptomycin + ampicillin/vancomycin
o Note: although ampicillin and vancomycin are cidal drugs, require this synergistic effect with the AMG to be cidal against enterococci

40
Q

What is aminoglycoside toxicity associated with?

A

Toxicity: nephortoxicity and ototoxicity associated with AUC or elevated trough concentrations, NOT PEAK CONCENTRATIONS!!

41
Q

Post Antibiotic Effect:

A

Definition: refers to the time period after removal of an antibiotic (or sub MIC concentrations) during which there is no bacterial growth

42
Q

Post antibiotic effect
Most classes of antibiotics have PAE against:

What have a longer PAE than cell wall active drugs?

What have PAE against Gram (-) bacilli for ~2-4 hours?

A

Most classes of antibiotics have PAE against aerobic Gram (+) cocci (except enterococcus)

Agents inhibiting RNA or protein synthesis often have a longer PAE than cell wall active drugs

AMGs, imipenem, and FQs have PAE against Gram (-) bacilli for ~2-4 hours (focus on AMG)

  • 2-4 hours without immune system help
  • Possibly up to 9 hours with help from the immune system

Micro Exam 1 (18 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions